期刊文献+

奈达铂联合5氟尿嘧啶对晚期食管癌患者CEA及SCC水平的影响及其临床疗效 被引量:10

Effect of Nedaplatin Combined with 5 Fluorouracil on the Levels of CEA and SCC in Patients with Advanced Esophageal Cancer and its Clinical Efficacy
原文传递
导出
摘要 目的:探讨奈达铂联合5-氟尿嘧啶对食管癌晚期患者CEA,SCC及临床疗效的影响。方法:收集我院收治的食管癌晚期患者60例,随机分为对照组和实验组,每组各30例,对照组患者给予顺铂+5-氟尿嘧啶的化疗方案,实验组患者给予奈达铂+5-氟尿嘧啶方案化疗。观察并比较两组患者治疗前后血清CEA及SCC水平的变化情况、毒副反应发生率以及临床疗效。结果:与治疗前相比,两组患者治疗后CEA及SCC水平均降低,差异具有统计学意义(P<0.05);与对照组相比,实验组患者治疗后CEA及SCC水平较低,差异具有统计学意义(P<0.05);与对照组比较,实验组患者毒副反应发生率较低,差异具有统计学意义(P<0.05);与对照组比较,实验组患者治疗有效率较高,差异具有统计学意义(P<0.05)。结论:奈达铂联合5氟尿嘧啶能够降低食管癌晚期患者CEA、SCC以及毒副反应发生率,提高治疗效果。 Objective: To investigate the effect of nedaplatin combined with 5 fluorouracil on the changes of CEA and SCC and its clinical efficacy for patients with advanced esophageal cancer. Methods: 60 patients with advanced esophageal cancer who were treated in our hospital were selected and randomly divided into the experiment group and the control group, with 30 cases in each group. The patients in the control group were treated with cisplatin 5-fluorouracil chemotherapy, while the patients in the experiment group were treated with the nedaplatin 5-fluorouracil(5-FU) chemotherapy. Then the changes of CEA and SCC, and the treatment toxic reaction rate and clinical efficacy were observed and compared before and after the treatment. Results: Compared with before treatment, the levels of CEA and SCC in the two groups decreased after the treatment, and the differences were statistically significant(P〈0.05); Compared with the control group, the levels of CEA and SCC in the experiment group were lower than those of the control group, and the differences were statistically significant(P〈0.05); The toxic reaction rate in the experiment group was lower than that of the control group, and the difference was statistically significant(P〈0.05); The clinical efficacy in the experiment group was higher than that of the control group,and the difference was statistically significant(P〈0.05). Conclusion: Nedaplatin combined with 5-fluorouracil can reduce the levels of CEA and SCC and the toxic reactions of patients with esophageal cancer, and improve the clinical efficacy.
出处 《现代生物医学进展》 CAS 2016年第18期3489-3491,3495,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30770971)
关键词 奈达铂 5氟尿嘧啶 食管癌 CEA SCC Nedaplatin 5-fluorouracil Esophageal carcinoma CEA SCC
  • 相关文献

参考文献20

  • 1Hiripi E, Jansen L, Gondos A, et al. Survival of stomach and esophagus cancer patients in Germany in the early 21st century[J]. Acta oncologica, 2012, 51(7): 906-914. 被引量:1
  • 2Khara H S, Jackson S A, Nair S, et al. Assessment of mutational load in biopsy tissue provides additional information about genomic instability to histological classifications of Barrett's esophagus [J]. Journal of gastrointestinal cancer, 2014, 45(2): 137-145. 被引量:1
  • 3Goscinski M A, Nesland J M, Giercksky K E, et al. Pri mary tumor vascularity in esophagus cancer. CD34 and HIFI-a expression correlate with tumor progression[J]. Histol Histopathol, 2013, 28(10): 1361-1368. 被引量:1
  • 4Echeverria A E, McCurdy M, Castillo R, et al. Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients [J]. Radiotherapy and Oneology, 2013, 106(1): 124-129. 被引量:1
  • 5Thrift A P, Kramer J R, Richardson P A, et al. No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus [J]. Digestive diseases and sciences, 2014, 59(1): 108-116. 被引量:1
  • 6Wang H B, Jiang Z B, Li M. Research on the typical mima and target genes in squamous cell carcinoma and adenocarcinoma of esophagus cancer with DNA microarray [J]. Pathology & Oncology Research,2014, 20(2): 245-252. 被引量:1
  • 7Nakao R, Fujita Y, Yagi N, et al. Histopathological and immunohistochemical characteristics of superficial squamous cell carcinoma forming droplet infiltration: indicator of lymph node metastasis of the esophagus[J]. Esophagus, 2015, 12(2): 175-183. 被引量:1
  • 8Kukar M, G-roman A, Malhotm U, et al. Small cell carcinoma of the esophagus: a SEER database analysis[J]. Annals of surgical oncology, 2013, 20(13): 4239-4244. 被引量:1
  • 9Chang K C, Chen Y L, Lai S W, et al. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan[J]. BMC gastroenterology, 2012, 12(1): 177. 被引量:1
  • 10Wang J, Chang J, Yu H, et al. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus [J]. Cancer chemotherapy and pharmacology, 2013, 71(4): 905-911. 被引量:1

同被引文献69

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部